Why the study?
Does fludrocortisone improve symptoms and physiological parameters in diabetics with postural hypotension due to autonomic neuropathy?
Does fludrocortisone improve symptoms and physiological parameters in diabetics with postural hypotension due to autonomic neuropathy?
Fludrocortisone effectively improves symptoms and physiological parameters of postural hypotension in diabetic autonomic neuropathy, but requires caution in patients with low serum albumin due to edema risk.
Supports fludrocortisone for postural hypotension in diabetic autonomic neuropathy; extends small RCT evidence but needs larger trials.
A double-blind crossover study of fludrocortisone, 0,1 mg. twice daily, and placebo is reported in six diabetics with troublesome symptoms of postural hypotension due to autonomic neuropathy. During treatment with the active preparation there was an increase in the lying and tilted systolic blood pressure, a decrease in orthostatic tachycardia, and in increase in the total plasma volume and body weight, but with no change in plasma or urine osmolality; The symptoms of postural hypotension improved in four patients, while two patients with a low serum albumin developed ankle edema during treatment with fludrocortisone. It is concluded that fludrocortisone is effective in diabetics with symptomatic postural hypotesnion, but should be used with caution in patients with a low serum albumin.
No takes yet. Share an insight, caveat, or question.
Campbell et al. (1975) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: